drugset / Trial / NCT02718430
VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis
NaSingle-groupOpen-labelTreatment
Summary
Phase I study in patients with metastatic colorectal cancer with liver metastasis under second or third line therapy to examine safety, efficacy, and immune biomarkers after treatment with VXM01
Timeline
- Start
- 2016-02
- Primary completion
- 2018-03
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VXM01 | Vaccine | 1e+07 unknown | Oral |
| Subject | VXM01 | Vaccine | 1e+08 unknown | Oral |